The deregulation of Hsp activities in hepatocellular carcinoma also promotes tumor cell proliferation and thus the inhibition of crucial Hsps is an attractive strategy to treat HCC [34,35]. The gene discussed is HSP90B2P; the disease is hepatocellular carcinoma.